Innovative immunotherapy targeting at PD-1/PD-L1 signaling pathway: mechanism, efficacy and safety analysis of monotherapy and combination therapies in non-small cell lung cancer (NSCLC) treatment
and
E3S Web Conf., 267 (2021) 02026
Published online: 04 June 2021
DOI: 10.1051/e3sconf/202126702026